Some of you may remember when I participated in the clinical trial for Gilenya, the first MS pill. (The saga starts here, back in 2007.) I was Spartacus, or at least Tony Curtis taking the hit for Spartacus, or at least an MS patient testing a drug that might help other MS patients.
Ten or so years later that trial finished and it was a great experience for me.
Well, some Facebook ad alerted me that there might be a Covid-related trial in the offing for the immunocompromised. I filled out the form and got a phone call from a charming Briton. (I took the chance to spell out my new drug, Mayzent, with a “zee as in … zed.”)
This trial is the Supernova trial, which will produce the next generation of monoclonal antibodies. That’s the Evusheld I took last October — only to be called days later with the news that it was useless because it didn’t protect again Omicron. This trial tests a new version that does include the Omicron variant, and maybe the variant that’s in China now.
During this trial there are only monthly visits to a nearby test center, plus the placebo is the previous old-school Evusheld, so even more protection against Alpha and Delta.
I’m excited. Clinical trials are my favorite hobby. I hope I make it in.
2 responses to “Again I Am Spartacus”
Ooooh. May it work well!
I have been in two research sets, but no med trials. I wish I could get into the tVNS or IVIG trials for my thing, though…
KC – The first hurdle is to get “certified” medical records from my doctor. That might just be there to see how motivated / compliant / detailed I am.